journal article·2025-09

Endothelial function-biomimetic hydrogel-surface engineered non-glutaraldehyde bioprosthetic valve with antithrombotic, immunomodulatory and pro-endothelialization performance

Lepeng Chen, Fengyao Chi, Xueyu Huang, Bangquan Wei, Li Yang, Rifang Luo, Cheng Zheng, Yunbing Wang

Acta Biomaterialia· Volume 204
Publisher page

Abstract

The progress of transcatheter valve replacement has significantly reduced the risk of valve replacement, increasing the demand for bioprosthetic heart valves (BHVs). Currently, the defects of BHVs, including thrombosis, poor endothelialization, calcification, and immune responses that are associated with glutaraldehyde crosslinking and their xenogeneic collagenous matrix, have accelerated the degeneration of BHVs. Herein, we constructed an endothelial function biomimetic hydrogel surface engineered non-glutaraldehyde BHV based on bioinspired catechol-crosslinking system and metal-chelation. An endothelial glycocalyx-like layer was anchored on BHV through the bioinspired oxidative coupling of catecholic porcine pericardium and alginate to mimic the endothelial glycocalyx on the inner wall of blood vessels, by which we also simultaneously achieved the crosslinking of BHV and the enrichment of bioactive catechols on BHV. Furthermore, the copper ions were introduced through chelation with alginate and catechol to impart glutathione peroxidase (GPx)-like functionality to BHVs, which mimicked the nitroxide (NO) generation performance of endothelium. The engineered BHV not only resisted the thrombosis, alleviated oxidative stress and modulated the immune responses but also facilitated the endothelialization. Moreover, the calcification of the BHVs was also significantly reduced in rat subcutaneous model. Altogether, this work presents significant potential to prolong the service life of BHVs. STATEMENT OF SIGNIFICANCE: Bioprosthetic heart valves (BHVs) are prone to degeneration due to thrombosis, poor endothelialization, calcification, and immune responses which are closely associated with the defects of glutaraldehyde crosslinking and their xenogeneic collagenous matrix. Based on catechol cross-linking and metal-phenol chemistry, we engineered a non-glutaraldehyde BHV with an endothelial function biomimetic hydrogel surface to prevent thrombosis, reduce calcification, and enhance endothelialization and immunomodulation. The endothelial function biomimetic hydrogel surface resists blood fouling and thrombosis, forming a catechol-rich entity to alleviate oxidative stress and modulate immune responses. The incorporation of copper ions confers GPx-like functionality, mimicking endothelial nitric oxide generation and facilitating the endothelialization. This work holds potential to extend the lifespan of BHVs and presents a promising candidate for the next generation of multi-functional BHVs.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Cardiac Valve Diseases and Treatments · Cardiac and Coronary Surgery Techniques · Electrospun Nanofibers in Biomedical Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (82)

Show source-provided references
1. TAVI and valve performance: update on definitions, durability, transcatheter heart valve failure modes and management
2. Transcatheter versus surgical pulmonary valve replacement: a systemic review and meta-analysis10.1016/j.athoracsur.2020.03.007 ↗
3. Thrombotic risk and antithrombotic strategies after transcatheter mitral valve replacement10.1016/j.jcin.2019.07.055 ↗
4. E.N.C. Societies, 2021 ESC/EACTS guidelines for the management of valvular heart disease: developed by the task force for the management of valvular heart disease of the10.1093/eurheartj/ehab395 ↗
5. Fixation of bovine pericardium-based tissue biomaterial with irreversible chemistry improves biochemical and biomechanical properties10.1007/s12265-017-9733-5 ↗
6. Optimizing glutaraldehyde-fixed tissue heart valves with chondroitin sulfate hydrogel for endothelialization and shielding against deterioration10.1021/acs.biomac.8b00077 ↗
7. Development of innovative biomaterials and devices for the treatment of cardiovascular diseases
8. Degeneration of bioprosthetic heart valves: update10.1161/JAHA.120.018506 ↗
9. Calcification and oxidative modifications are associated with progressive bioprosthetic heart valve dysfunction10.1161/JAHA.117.005648 ↗
10. Leaflet immobility and thrombosis in transcatheter aortic valve replacement10.1093/eurheartj/ehaa542 ↗
11. Bioprosthetic valve thrombosis and degeneration following transcatheter aortic valve implantation (TAVI)10.1016/j.crad.2020.08.015 ↗
12. Recent progress in functional modification and crosslinking of bioprosthetic heart valves
13. Versatile polyphenolic platforms in regulating cell biology10.1039/D1CS01165K ↗
14. Polyphenol scaffolds in tissue engineering10.1039/D0MH01317J ↗
15. Antioxidative and antibacterial gallium (III)-phenolic coating for enhanced osseointegration of titanium implants via pro-osteogenesis and inhibiting osteoclastogenesis10.1016/j.biomaterials.2023.122268 ↗
16. Polyphenol uses in biomaterials engineering10.1016/j.biomaterials.2018.03.018 ↗
17. Mimicking biological functionality with polymers for biomedical applications10.1038/nature21005 ↗
18. Robust, sprayable, and multifunctional hydrogel coating through a polycation reinforced (PCR) surface bridging strategy10.1002/adma.202310216 ↗
19. Structures, properties, and bioengineering applications of alginates and hyaluronic acid10.3390/polym15092149 ↗
20. Alginate encapsulation as long-term immune protection of allogeneic pancreatic islet cells transplanted into the omental bursa of macaques10.1038/s41551-018-0275-1 ↗
21. Folding artificial mucosa with cell-laden hydrogels guided by mechanics models10.1073/pnas.1802361115 ↗
22. Synergistic enzymatic and bioorthogonal reactions for selective prodrug activation in living systems10.1038/s41467-018-07490-6 ↗
23. Nitric oxide release: part II. Therapeutic applications10.1039/c2cs15273h ↗
24. Role of eNOS in neovascularization: no for endothelial progenitor cells10.1016/j.molmed.2004.02.001 ↗
25. Hydrogel cross-linking–programmed release of nitric oxide regulates source-dependent angiogenic behaviors of human mesenchymal stem cell10.1126/sciadv.aay5413 ↗
26. Promoting the healing of infected diabetic wound by an anti-bacterial and nano-enzyme-containing hydrogel with inflammation-suppressing, ROS-scavenging, oxygen and nitric oxide-generating properties10.1016/j.biomaterials.2022.121597 ↗
27. Bioinspired NO release coating enhances endothelial cells and inhibits smooth muscle cells10.1039/D1TB01828K ↗
28. A versatile passivated protein-adsorption platform for rapid healing of vascular stents by modulating the microenvironment10.1002/adfm.202312243 ↗
29. Metal-phenolic surfaces for generating therapeutic nitric oxide gas10.1021/acs.chemmater.8b01876 ↗
30. Mimicking the nitric oxide-releasing and glycocalyx functions of endothelium on vascular stent surfaces10.1002/advs.202002330 ↗
31. A polyphenol-network-mediated coating modulates inflammation and vascular healing on vascular stents10.1021/acsnano.2c00642 ↗
32. Y. Zhou, G. Yan, S. Wen, W.Y. Yim, Z. Wang, X. Chen, Y. Xu, X. Chen, H. Cao, P. Bai, F. Li, J. Shi, J. Wang, W. Qiao, N. Dong, Nitric oxide generation and endothelial progenitor cells recruitment for improving hemocompatibility and accelerating endothelialization of tissue engineering heart valve, 33(9) (2023) 2211267.10.1002/adfm.202211267 ↗
33. Immobilization of nano Cu-MOFs with polydopamine coating for adaptable gasotransmitter generation and copper ion delivery on cardiovascular stents10.1016/j.biomaterials.2019.03.007 ↗
34. The molecular mechanisms of copper metabolism and its roles in human diseases10.1007/s00424-020-02412-2 ↗
35. Copper homeostasis and copper-induced cell death in the pathogenesis of cardiovascular disease and therapeutic strategies10.1038/s41419-023-05639-w ↗
36. A tough nitric oxide-eluting hydrogel coating suppresses neointimal hyperplasia on vascular stent10.1038/s41467-021-27368-4 ↗
37. Egg-box model-based gelation of alginate and pectin: a review10.1016/j.carbpol.2020.116389 ↗
38. Ion-induced polysaccharide gelation: peculiarities of Alginate egg-box association with different divalent cations10.3390/polym15051243 ↗
39. Mussel-inspired dopamine-CuII coatings for sustained in situ generation of nitric oxide for prevention of stent thrombosis and restenosis10.1016/j.biomaterials.2018.12.020 ↗
40. Underwater contact behavior of Alginate and catechol-conjugated alginate hydrogel beads10.1021/acs.langmuir.7b00795 ↗
41. Interactions of U937 macrophage-like cells with decellularized pericardial matrix materials: influence of crosslinking treatment10.1016/j.actbio.2013.02.021 ↗
42. Copper-based metal–Organic framework as a controllable nitric oxide-releasing vehicle for enhanced diabetic wound healing10.1021/acsami.0c01792 ↗
43. Effect of pore size on ECM secretion and cell growth in gelatin scaffold for articular cartilage tissue engineering10.1016/j.actbio.2008.09.020 ↗
44. A PEGylation method of fabricating bioprosthetic heart valves based on glutaraldehyde and 2-amino-4-pentenoic acid co-crosslinking with improved antithrombogenicity and cytocompatibility10.1016/j.actbio.2022.03.026 ↗
45. Epigallocatechin-3-gallate (EGCG) based metal-polyphenol nanoformulations alleviates chondrocytes inflammation by modulating synovial macrophages polarization
46. A versatile glycopeptide hydrogel promotes chronic refractory wound healing through bacterial elimination, sustained oxygenation, immunoregulation, and neovascularization10.1002/adfm.202305992 ↗
47. NIR/glucose stimuli-responsive multifunctional smart hydrogel wound dressing with NO/O2 dual gas-releasing property promotes infected diabetic wound healing10.1016/j.cej.2024.152249 ↗
48. XPS study of group IA carbonates10.2478/BF02475578 ↗
49. Visual semiquantification via the formation of phase segregation10.1021/ac200242j ↗
50. Lysosomal deposition of copper oxide nanoparticles triggers HUVEC cells death10.1016/j.biomaterials.2018.01.048 ↗
51. Mechanical considerations for polymeric heart valve development: biomechanics, materials, design and manufacturing10.1016/j.biomaterials.2019.119493 ↗
52. Factors affecting thermal stability of collagen from the aspects of extraction, processing and modification10.1186/s42825-020-00033-0 ↗
53. Collagen fibre-mediated mechanical damage increases calcification of bovine pericardium for use in bioprosthetic heart valves10.1016/j.actbio.2021.04.046 ↗
54. Protein adsorption of calcified and noncalcified valvular bioprostheses after human implantation10.1016/S0003-4975(01)02501-2 ↗
55. The quest for blood-compatible materials: recent advances and future technologies10.1016/j.mser.2019.06.002 ↗
56. Interfacial material system exhibiting superwettability10.1002/adma.201400883 ↗
57. Microgel reinforced zwitterionic hydrogel coating for blood-contacting biomedical devices10.1038/s41467-022-33081-7 ↗
58. Sterilization and disinfection methods for decellularized matrix materials: review, consideration and proposal
59. The canonical smooth muscle cell marker TAGLN is present in endothelial cells and is involved in angiogenesis10.1242/jcs.254920 ↗
60. Inhibition of the PI3K–Akt and mTORC1 signaling pathways promotes the elongation of vascular endothelial cells10.1242/jcs.178434 ↗
61. Infections and endothelial cells10.1016/S0008-6363(03)00354-7 ↗
62. Strategies to develop endogenous stem cell-recruiting bioactive materials for tissue repair and regeneration10.1016/j.addr.2017.07.011 ↗
63. A promoting nitric oxide-releasing coating containing copper ion on ZE21B alloy for potential vascular stent application10.1016/j.jma.2022.08.004 ↗
64. Copper-based SURMOFs for nitric oxide generation: hemocompatibility
65. Sustained activation of XBP1 splicing leads to endothelial apoptosis and atherosclerosis development in response to disturbed flow10.1073/pnas.0903197106 ↗
66. Chemokine CXCL1 mediated neutrophil recruitment: role of glycosaminoglycan interactions10.1038/srep33123 ↗
67. GATA3-induced vWF upregulation in the lung adenocarcinoma vasculature10.18632/oncotarget.22806 ↗
68. Current understanding of tyrosine kinase BMX in inflammation and its inhibitors10.4103/2321-3868.135483 ↗
69. The lncRNA GATA6-AS epigenetically regulates endothelial gene expression via interaction with LOXL210.1038/s41467-017-02431-1 ↗
70. Pan-cancer analysis on the role of PIK3R1 and PIK3R2 in human tumors10.1038/s41598-022-09889-0 ↗
71. PI3K/AKT/mTOR pathway in angiogenesis10.3389/fnmol.2011.00051 ↗
72. Wnt3a regulates proliferation and migration of HUVEC via canonical and non-canonical Wnt signaling pathways10.1016/j.bbrc.2009.06.033 ↗
73. Sies · Oxidative Stress Annu Rev. Biochem. · 2017 · 86 · 71510.1146/annurev-biochem-061516-045037 ↗
74. Ultra-small copper-based multienzyme-like nanoparticles protect against hepatic ischemia-reperfusion injury through scavenging reactive oxygen species in mice10.1002/smll.202403313 ↗
75. Noncalcific mechanisms of bioprosthetic structural valve degeneration10.1161/JAHA.120.018921 ↗
76. Activation of NAD(P)H oxidase by tryptophan-derived 3-hydroxykynurenine accelerates endothelial apoptosis and dysfunction In vivo10.1161/CIRCRESAHA.114.302113 ↗
77. Mesenchymal stem cell-macrophage crosstalk and bone healing10.1016/j.biomaterials.2017.12.025 ↗
78. Oxidative stress in structural valve deterioration: a longitudinal clinical study10.3390/biom12111606 ↗
79. Nitric oxide: physiological functions, delivery, and biomedical applications10.1002/advs.202303259 ↗
80. Vascular inflammation, insulin resistance, and reduced nitric oxide production precede the onset of peripheral insulin resistance10.1161/ATVBAHA.108.169722 ↗
81. Calcification of tissue heart valve substitutes: progress toward understanding and prevention10.1016/j.athoracsur.2004.06.033 ↗
82. Biochemical and histological evidence of deteriorated bioprosthetic valve leaflets: the accumulation of fibrinogen and plasminogen10.1242/bio.034009 ↗